Objective: To study the expressions and significations of metallothionein (MT) in cervical squamous cell cancer (CSC), bladder transitional cell cancer (BTC) and breast cancer (BC) of woman. Methods: Immunohistochemical method was used to examine the expresses rate of MT in three types of woman cancer tissue. Results: The expressions rates of MT were 54.35% (29/46) in BTC, 67.05% (59/88) in BC and 57.14% (40/70) in CSC. The positive rate of MT expression was higher in low differentiation group than well differentiation group in BTC and CSC (P < 0.05). Positive of MT in lobular cancer was significance higher than medullary and duct cancers (P < 0.05). Conclusion: The expression of MT is related to differentiation degree, and it is a guidance for clinical choice of chemotherapy project. Objective: To study the expressions and significations of metallothionein (MT) in cervical squamous cell cancer (CSC), bladder transitional cell cancer (BTC) and breast cancer (BC) of woman. Methods: Immunohistochemical method was used to examine the expresses rate of Results: The expressions rates of MT were 54.35% (29/46) in BTC, 67.05% (59/88) in BC and 57.14% (40/70) in CSC. The positive rate of MT expression was higher in low differentiation group than well differentiation group in BTC and CSC (P <0.05). Positive of MT in lobular cancer was significance higher than medullary and duct cancers (P <0.05). Conclusion: The expression of MT is related to differentiation degree, and it is a guidance for clinical choice of chemotherapy project.